Anti-IL-23 antibodies

US10576150B2 · kind B2 · utility

Assignee

• JANSSEN BIOTECH, INC. · US

Inventors

• Jacqueline Benson · Malvern, US
• Mark Cunningham · Kennett Square, US
• Cynthia Duchala · North Wales, US
• Jill Giles-Komar · Downingtown, US
• Jinquan Luo · Malvern, US
• Michael Rycyzyn · Berwyn, US
• Raymond Sweet · Via Enrico Fermi, US

Key dates

• Filing date: Mar 20, 2019
• Grant date: Mar 3, 2020
• Expiry date: Mar 20, 2039

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.